Chuck Y. Mah

Array ( [id] => 3772883 [patent_doc_number] => 05807854 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Pyrimidone derivatives with antifungal activity' [patent_app_type] => 1 [patent_app_number] => 8/809967 [patent_app_country] => US [patent_app_date] => 1997-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30607 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 772 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807854.pdf [firstpage_image] =>[orig_patent_app_number] => 809967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216752 [patent_doc_number] => 06706705 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-16 [patent_title] => 'Quinazoline derivatives' [patent_app_type] => B1 [patent_app_number] => 08/809770 [patent_app_country] => US [patent_app_date] => 1997-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3403 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706705.pdf [firstpage_image] =>[orig_patent_app_number] => 08809770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933793 [patent_doc_number] => 05939415 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => '›A!-annellated pyrrole derivatives and their use in pharmacology' [patent_app_type] => 1 [patent_app_number] => 8/737920 [patent_app_country] => US [patent_app_date] => 1997-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11171 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 525 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939415.pdf [firstpage_image] =>[orig_patent_app_number] => 737920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828175 [patent_doc_number] => 05760029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Spirocycle integrin inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/816580 [patent_app_country] => US [patent_app_date] => 1997-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58705 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760029.pdf [firstpage_image] =>[orig_patent_app_number] => 816580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809429 [patent_doc_number] => 05811423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Benzoxazinones as inhibitors of HIV reverse transcriptase' [patent_app_type] => 1 [patent_app_number] => 8/815780 [patent_app_country] => US [patent_app_date] => 1997-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10993 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811423.pdf [firstpage_image] =>[orig_patent_app_number] => 815780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4025710 [patent_doc_number] => 05883094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Benzimidazolone derivatives with central dopaminergic activity' [patent_app_type] => 1 [patent_app_number] => 8/750479 [patent_app_country] => US [patent_app_date] => 1997-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5907 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 296 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/883/05883094.pdf [firstpage_image] =>[orig_patent_app_number] => 750479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809465 [patent_doc_number] => 05811425 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Heterocyclic compounds as COX-2 inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/812096 [patent_app_country] => US [patent_app_date] => 1997-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9872 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811425.pdf [firstpage_image] =>[orig_patent_app_number] => 812096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833507 [patent_doc_number] => 05814630 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Quinazoline compounds' [patent_app_type] => 1 [patent_app_number] => 8/800830 [patent_app_country] => US [patent_app_date] => 1997-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10805 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814630.pdf [firstpage_image] =>[orig_patent_app_number] => 800830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4058327 [patent_doc_number] => 05863916 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => '8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor' [patent_app_type] => 1 [patent_app_number] => 8/795387 [patent_app_country] => US [patent_app_date] => 1997-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 27271 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863916.pdf [firstpage_image] =>[orig_patent_app_number] => 795387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795643 [patent_doc_number] => 05780628 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Process for producing dioxoquinazolines' [patent_app_type] => 1 [patent_app_number] => 8/791551 [patent_app_country] => US [patent_app_date] => 1997-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4856 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780628.pdf [firstpage_image] =>[orig_patent_app_number] => 791551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3888883 [patent_doc_number] => 05723607 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'Compounds useful as antiproliferative agents and GARFT inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/792572 [patent_app_country] => US [patent_app_date] => 1997-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15817 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723607.pdf [firstpage_image] =>[orig_patent_app_number] => 792572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775305 [patent_doc_number] => 05756730 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Process for preparing analgesic compounds' [patent_app_type] => 1 [patent_app_number] => 8/789941 [patent_app_country] => US [patent_app_date] => 1997-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17790 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 374 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756730.pdf [firstpage_image] =>[orig_patent_app_number] => 789941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3815187 [patent_doc_number] => 05789410 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands' [patent_app_type] => 1 [patent_app_number] => 8/787213 [patent_app_country] => US [patent_app_date] => 1997-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5680 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789410.pdf [firstpage_image] =>[orig_patent_app_number] => 787213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939627 [patent_doc_number] => 05872125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Polymorphs of lesopitron dihydrochloride and its hydrated forms, preparation processes and compositions containing it' [patent_app_type] => 1 [patent_app_number] => 8/776113 [patent_app_country] => US [patent_app_date] => 1997-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3500 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872125.pdf [firstpage_image] =>[orig_patent_app_number] => 776113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828390 [patent_doc_number] => 05760041 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => '4-aminoquinazoline EGFR Inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/785910 [patent_app_country] => US [patent_app_date] => 1997-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9580 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760041.pdf [firstpage_image] =>[orig_patent_app_number] => 785910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4008669 [patent_doc_number] => 05889002 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/785438 [patent_app_country] => US [patent_app_date] => 1997-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14320 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 347 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889002.pdf [firstpage_image] =>[orig_patent_app_number] => 785438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3859939 [patent_doc_number] => 05792764 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/785435 [patent_app_country] => US [patent_app_date] => 1997-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11246 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 760 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792764.pdf [firstpage_image] =>[orig_patent_app_number] => 785435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828865 [patent_doc_number] => 05783698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Chemical synthesis of 1,3-disubstituted quinazolinediones' [patent_app_type] => 1 [patent_app_number] => 8/779498 [patent_app_country] => US [patent_app_date] => 1997-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2213 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783698.pdf [firstpage_image] =>[orig_patent_app_number] => 779498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828159 [patent_doc_number] => 05760028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Integrin receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 8/770538 [patent_app_country] => US [patent_app_date] => 1996-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 108192 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760028.pdf [firstpage_image] =>[orig_patent_app_number] => 770538 [rel_patent_id] =>[rel_patent_doc_number] =>)